Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Young Min Cho

Showing results (1-10 of 289) with videos related to

Pageof 29
Sort By:
Journal of Diabetes Investigation|November 30, 2022
Glucagon-like peptide-1 therapy for youth with type 2 diabetesYoung Min Cho
Journal of Diabetes Investigation|September 30, 2015
Incretin physiology and pathophysiology from an Asian perspectiveYoung Min Cho
Journal of Diabetes Investigation|November 7, 2015
Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?Young Min Cho
Diabetes & Metabolism Journal|December 27, 2014
A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgeryYoung Min Cho
Diabetes & Metabolism Journal|April 30, 2015
Erratum: figure correction. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgeryYoung Min Cho
The Lancet. Diabetes & Endocrinology|March 11, 2015
To mix or to separate: that is the questionYoung Min Cho
Clinical Immunology (Orlando, Fla.)|November 30, 2023
Natural supplements in antiphospholipid syndrome: A case for further studyNina Kello, Young Min Cho
Immunotherapy|October 25, 2023
The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosusYoung Min Cho, Richard Furie
Journal of Diabetes Investigation|July 21, 2020
Invincible β-cells in type 1 diabetesHun Jee Choe, Young Min Cho
Journal of Diabetes|May 22, 2020
Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney diseaseSun Joon Moon, Young Min Cho
Pageof 29

Showing results (1-10 of 289) with videos related to

Sort By:
Pageof 29
Journal of Diabetes Investigation|November 30, 2022
Glucagon-like peptide-1 therapy for youth with type 2 diabetesYoung Min Cho
Journal of Diabetes Investigation|September 30, 2015
Incretin physiology and pathophysiology from an Asian perspectiveYoung Min Cho
Journal of Diabetes Investigation|November 7, 2015
Cardiovascular effects of the incretin-based therapy: the good, the bad, or the ugly?Young Min Cho
Diabetes & Metabolism Journal|December 27, 2014
A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgeryYoung Min Cho
Diabetes & Metabolism Journal|April 30, 2015
Erratum: figure correction. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgeryYoung Min Cho
The Lancet. Diabetes & Endocrinology|March 11, 2015
To mix or to separate: that is the questionYoung Min Cho
Clinical Immunology (Orlando, Fla.)|November 30, 2023
Natural supplements in antiphospholipid syndrome: A case for further studyNina Kello, Young Min Cho
Immunotherapy|October 25, 2023
The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosusYoung Min Cho, Richard Furie
Journal of Diabetes Investigation|July 21, 2020
Invincible β-cells in type 1 diabetesHun Jee Choe, Young Min Cho
Journal of Diabetes|May 22, 2020
Economic benefit of prescribing an adjusted renal dose of dipeptidyl peptidase IV inhibitors in type 2 diabetes patients with chronic kidney diseaseSun Joon Moon, Young Min Cho
Pageof 29